Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease (PHEDRE)
PHEDRE Trial Protocol - Observational Study of the Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and Analgesics in the French Sickle-cell Disease Population
Sponsor: Nantes University Hospital
A observational or N/A phase clinical study on Sickle Cell Disease, this trial is completed. The trial is conducted by Nantes University Hospital and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nantes University Hospital
- University Hospital, Clermont-Ferrand
- University Hospital, Lille
- University Hospital, Marseille
- University Hospital, Paris
- University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.